These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
223 related articles for article (PubMed ID: 32049832)
1. Comparative risk of Selective Serotonin Reuptake Inhibitors (SSRIs)-induced nausea among Chinese senile depression patients: A network meta-analysis of randomized-controlled trials. Guo S; Yang Y; Pei XJ; Liu FY Medicine (Baltimore); 2020 Feb; 99(7):e19133. PubMed ID: 32049832 [TBL] [Abstract][Full Text] [Related]
2. Comparative cardiovascular safety of selective serotonin reuptake inhibitors (SSRIs) among Chinese senile depression patients: A network meta-analysis of randomized controlled trials. Guo S; Chen L; Cheng S; Xu H Medicine (Baltimore); 2019 May; 98(22):e15786. PubMed ID: 31145302 [TBL] [Abstract][Full Text] [Related]
3. Use of Bayesian net benefit regression model to examine the impact of generic drug entry on the cost effectiveness of selective serotonin reuptake inhibitors in elderly depressed patients. Shih YC; Bekele NB; Xu Y Pharmacoeconomics; 2007; 25(10):843-62. PubMed ID: 17887806 [TBL] [Abstract][Full Text] [Related]
4. Pharmacological interventions for the treatment of depression in chronic obstructive pulmonary disease. Pollok J; van Agteren JE; Carson-Chahhoud KV Cochrane Database Syst Rev; 2018 Dec; 12(12):CD012346. PubMed ID: 30566235 [TBL] [Abstract][Full Text] [Related]
5. A systematic review of Chinese randomized clinical trials of SSRI treatment of depression. Zhang Y; Becker T; Ma Y; Koesters M BMC Psychiatry; 2014 Aug; 14():245. PubMed ID: 25159460 [TBL] [Abstract][Full Text] [Related]
6. Systematic review and guide to selection of selective serotonin reuptake inhibitors. Edwards JG; Anderson I Drugs; 1999 Apr; 57(4):507-33. PubMed ID: 10235690 [TBL] [Abstract][Full Text] [Related]
7. Efficacy of escitalopram in the treatment of major depressive disorder compared with conventional selective serotonin reuptake inhibitors and venlafaxine XR: a meta-analysis. Kennedy SH; Andersen HF; Lam RW J Psychiatry Neurosci; 2006 Mar; 31(2):122-31. PubMed ID: 16575428 [TBL] [Abstract][Full Text] [Related]
8. Comparative efficacy of selective serotonin reuptake inhibitors (SSRI) in treating major depressive disorder: a protocol for network meta-analysis of randomised controlled trials. Jia Y; Zhu H; Leung SW BMJ Open; 2016 Jun; 6(6):e010142. PubMed ID: 27267106 [TBL] [Abstract][Full Text] [Related]
9. Comparative Cardiac Safety of Selective Serotonin Reuptake Inhibitors among Individuals Receiving Maintenance Hemodialysis. Assimon MM; Brookhart MA; Flythe JE J Am Soc Nephrol; 2019 Apr; 30(4):611-623. PubMed ID: 30885935 [TBL] [Abstract][Full Text] [Related]
11. Selective serotonin reuptake inhibitors in major depression disorder treatment: an umbrella review on systematic reviews. Ghaffari Darab M; Hedayati A; Khorasani E; Bayati M; Keshavarz K Int J Psychiatry Clin Pract; 2020 Nov; 24(4):357-370. PubMed ID: 32667275 [TBL] [Abstract][Full Text] [Related]
12. Selective serotonin reuptake inhibitors (SSRIs) for depressive disorders in children and adolescents. Hetrick S; Merry S; McKenzie J; Sindahl P; Proctor M Cochrane Database Syst Rev; 2007 Jul; (3):CD004851. PubMed ID: 17636776 [TBL] [Abstract][Full Text] [Related]
13. Depression treatment with selective serotonin reuptake inhibitors for the postacute coronary syndrome population: a literature review. Regan KL J Cardiovasc Nurs; 2008; 23(6):489-96. PubMed ID: 18953212 [TBL] [Abstract][Full Text] [Related]
14. Selective serotonin reuptake inhibitors (SSRIs) in the treatment of elderly depressed patients: a qualitative analysis of the literature on their efficacy and side-effects. Menting JE; Honig A; Verhey FR; Hartmans M; Rozendaal N; de Vet HC; van Praag HM Int Clin Psychopharmacol; 1996 Sep; 11(3):165-75. PubMed ID: 8923095 [TBL] [Abstract][Full Text] [Related]
15. What are the risks associated with different Selective Serotonin Re-uptake Inhibitors (SSRIs) to treat depression and anxiety in pregnancy? An evaluation of current evidence. Womersley K; Ripullone K; Agius M Psychiatr Danub; 2017 Sep; 29(Suppl 3):629-644. PubMed ID: 28953843 [TBL] [Abstract][Full Text] [Related]
16. The effect of venlafaxine compared with other antidepressants and placebo in the treatment of major depression: a meta-analysis. Bauer M; Tharmanathan P; Volz HP; Moeller HJ; Freemantle N Eur Arch Psychiatry Clin Neurosci; 2009 Apr; 259(3):172-85. PubMed ID: 19165525 [TBL] [Abstract][Full Text] [Related]
17. Risks of Digestive System Side-Effects of Selective Serotonin Reuptake Inhibitors in Patients with Depression: A Network Meta-Analysis. Wang Z; Li H; Kang Y; Liu Y; Shan L; Wang F Ther Clin Risk Manag; 2022; 18():799-812. PubMed ID: 35992228 [TBL] [Abstract][Full Text] [Related]
18. Bupropion versus selective serotonin-reuptake inhibitors for treatment of depression. Nieuwstraten CE; Dolovich LR Ann Pharmacother; 2001 Dec; 35(12):1608-13. PubMed ID: 11793630 [TBL] [Abstract][Full Text] [Related]
19. Escitalopram in the treatment of major depressive disorder: a meta-analysis. Kennedy SH; Andersen HF; Thase ME Curr Med Res Opin; 2009 Jan; 25(1):161-75. PubMed ID: 19210149 [TBL] [Abstract][Full Text] [Related]
20. Milnacipran and selective serotonin reuptake inhibitors in major depression. Lopez-Ibor J; Guelfi JD; Pletan Y; Tournoux A; Prost JF Int Clin Psychopharmacol; 1996 Sep; 11 Suppl 4():41-6. PubMed ID: 8923126 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]